3 Year return

15.32%
20222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Launched on January 2013 (12 years)

Investment Details

₹NA

Minimum SIP Amount

₹5000

Minimum one time investment

Fund has no lock-in period

Calculate Returns

Based on past performance of this fund

ENTER AMOUNT

Your Investment ₹3,00,000
Gain
  • Total Value

Risk Involved

scale

Your principal will be at

Very High Risk

Scheme Information

Asset Under Management

₹7132.82 Cr.

Expense Ratio

0.92% (inclusive of GST)

Exit Load

1% if redeemed or switchd out on or efore completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units.

Ratings

ARQ Rating
0

Ratings by other agencies

0
0
0

Tax Implications

Withdrawal within 1 year

Exit load + 15% tax on gains

Withdrawal after 1 year

10% tax on gains over ₹1 Lakh per financial year

Fund Holdings

Holdings
₹7132.82Crores

Nippon India Mutual Fund Managers

SB

Sailesh Raj Bhan

Fund Manager since May 2018

View Details

Fund House Details

Nippon India Mutual Fund

Nippon India Mutual Fund Asset management company

AUM ₹433,896.92 Cr.
No. of Schemes 293
Setup Date June 1995

Peer Comparison

Comparison with other similar funds

Schemes by Nippon India Mutual Fund

List of mutual fund schemes by AMC

About Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment

Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is managed by Nippon Life India Asset Management Limited, formerly known as Reliance Nippon Life Asset Management Limited. Categorised as Sectoral/Thematic Funds, this fund focuses on investing in companies within a specific sector or theme, in this case, the pharmaceutical sector. Sectoral funds like this one concentrate on specific industries, aiming to benefit from the growth potential of that sector. Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is an open-ended fund, meaning investors can buy or sell units of the fund at any time, within market hours.

Investment Objective of the Scheme

The primary investment objective of the Nippon India Pharma Fund Direct Plan Growth Plan Bonus Reinvestment is to seek long-term capital appreciation by primarily investing in equity and equity-related securities of companies in the pharmaceutical sector.

Key Features of The Fund

5-year return 25.74%
Expense Ratio 0.92%
Fund Manager Sailesh Raj Bhan
Fund Size ₹7132.82 Cr
Risk Profile Very High

Is This Scheme Right for Me?

This fund might be suitable for investors who have a positive outlook on the pharmaceutical sector and want to allocate a portion of their funds to this specific industry. Sectoral funds can offer higher potential returns but also come with concentrated risk. So, investors with low-risk tolerance should not consider this fund. Interested investors should also bear in mind the potential volatility of the pharmaceutical sector before making a decision.

AMC Contact Details

Name Nippon India Mutual Fund
Launch Date June 1995
Addresss Nippon Life India Asset Management Limited, 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W), Mumbai – 400 013
Contact 1860 266 0111
Email customercare@nipponindiaim.in
Website https://mf.nipponindiaim.com/

Disclaimer: Mutual funds are subject to market risk. Read all scheme-related documents carefully to make informed-decision.

Invest Smart, Start Your SIP Today

Take control of your financial future by using our systematic investment plan calculator. All you have to do is input your desired investment amount and time horizon into our SIP calculator. Witness firsthand the potential growth of your investments as you tailor your strategy to match your unique financial objectives. With a personalised approach, you can ensure steady wealth accumulation over time, bringing you closer to your financial goals.

FAQs

What is today's NAV of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment?

NAV, or Net Asset Value, is the price of a single unit of a mutual fund. It is calculated by dividing the current value of holdings held by the mutual fund scheme at the end of the day by the total number of units issued. The NAV changes every day. The NAV of Nippon India Pharma Fund Direct Plan Growth Bonus Reinvestment on May 29 2024, is ₹482.0148